Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance

doi:10.3748/wjg.v10.i20.2936

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3075)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

305

HTML

2291

Figures (1-3)

258

Tables (1-2)

221

Sum=3075

Oct 15, 2004 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (39)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Oct 15, 2004; 10(20): 2936-2939
Published online Oct 15, 2004. doi: 10.3748/wjg.v10.i20.2936

Table 1 Cyclin D1 expression in early stage gastric carcinoma (EC), advanced gastric carcinoma (AC) and lymph node me-tastasis (LNM) and five-year survival

Cyclin D1	EC	AC	LNM	5-year survival rate
Cyclin D1	EC	AC	LNM	Alive	Dead
Positive	13	20	8	9	11
Negative	14	22	8	15	7
Total	27	42	16	24	18

Citation: Gao P, Zhou GY, Liu Y, Li JS, Zhen JH, Yuan YP. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance. World J Gastroenterol 2004; 10(20): 2936-2939
URL: https://www.wjgnet.com/1007-9327/full/v10/i20/2936.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i20.2936